@article{APS9446,
author = {Yi-ming YUAN and Jin-long ZHANG and Si-cheng XU and Ren-song YE and Dan XU and You ZHANG and Yan-Jie ZHANG and Yu-long CHEN and Yu-lan LIU and Zhi-guang SU},
title = {Genetic variants of CDH13 determine the susceptibility to chronic obstructive pulmonary disease in a Chinese population},
journal = {Acta Pharmacologica Sinica},
volume = {37},
number = {3},
year = {2017},
keywords = {},
abstract = {Aim: Adiponectin has been implicated in the development of chronic obstructive pulmonary disease (COPD). The CDH13 gene encodes T-cadherin that is an adiponectin receptor, and genetic variants of CDH13 determine blood adiponectin levels. The aim of this study was to investigate the effects of CDH13 variants on COPD susceptibility in a Chinese population.
Methods: Ten single-nucleotide polymorphisms (SNP) in CDH13 were screened using the SNaPshot method in 279 COPD patients and 367 control subjects. Association of genotypes or haplotypes constructed from these loci with COPD was analyzed in different genetic models.
Results: Among the 10 SNPs tested, rs4783244 and rs12922394 exhibited significant differences in allele or genotype frequencies between COPD patients and control subjects, whereas 8 other SNPs did not. The minor allele T was associated with decreased risk of COPD in the recessive model at rs4783244 (OR=0.42, P=0.023) and in the dominant model at rs12922394 (OR=0.70, P=0.022). The genotype TT at either rs4783244 or rs12922394 was associated with a significantly low level of plasma adiponectin when compared to genotypes GG and CC (P},
issn = {1745-7254}, url = {http://www.chinaphar.com/article/view/9446}
}